Abstract
International collaboration could facilitate systematic development of guidelines to regulate and improve clinical practice. Insight into existing international guidelines regarding hypertensive disorders in pregnancy (HDP) is essential. Aim was to evaluate the content and quality of international clinical guidelines on HDP. Quality was assessed with the internationally validated Appraisal of Guidelines for Research and Evaluation (AGREE II) Instrument. Six guidelines were identified. Quality was moderate to high. Major flaws were applicability, editorial independence and stakeholder involvement. Recommendations differed considerably, particularly their extensiveness. The number of international HDP guidelines is small and the extensiveness of their recommendations varies considerably. © 2013 Informa Healthcare USA, Inc. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 367-377 |
| Journal | Hypertension in Pregnancy |
| Volume | 32 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 16 Peace, Justice and Strong Institutions
-
SDG 17 Partnerships for the Goals
Fingerprint
Dive into the research topics of 'Hypertensive disorders in pregnancy: a review of international guidelines'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver